Bone Marrow Transplantation Research

Research and Treatment Protocols

See all research and treatment protocols

AAML05P1: Killer Immunoglobulin-like Receptor (KIR) Incompatible Hematopoietic Cell Transplant (HCT) for Refractory and Relapsed Acute Myelogenous Leukemia (AML) and newly diagnosed AML with monosomy 7 or -5/5q- in Children
PCT: Cryopreservation of Autologous or Allogeneic PBSC
HCT Data: Stem Cell Transplant Registries
ACCL1031: A Randomized Double Blinded Trial of topical Caphosol to Prevent Oral Mucositis in Children Undergoing HSCT
ACCL1131: A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections following HSCT

 

 Defibrotide: Defibrotide for HSCT Patients with Severe VOD
NMDP: A Multicenter research Database for Allogeneic Unrelated HSCT (Research Sample Repository)
NMDP: A Multicenter Research Database for Allogeneic Related HSCT (Research Sample Repository)
10-CBA: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications
Wash U: A Study of HSCT in Non-Malignant Disease Using a Reduced Intensity Preparatory Regimen

BMTCTN 0601: Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children with Severe Sickle Cell Disease
11-TREO: A Phase II Study of Treosulfan, Fludarabine And Low-dose Total Body Irradiation (TBI) as a Preparative Regimen for Children with AML/MDS Undergoing Allogeneic HSCT
RD Safe: A Multicenter Study of HSC Donor Safety and Quality of Life
275: Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute GVHD

STALLO: Pilot Study of Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MCH Mismatched Related Donors and a Sub-myeloablative Regimen
STALLONe: Phase I Study Of Donor Derived, Multi-virus-specific, Cytotoxic T-lymphocytes Redirected To The Tumor Marker GD2 In Patients With Relapsed/Refractory Neuroblastoma Post-allogeneic Hematopoietic Stem Cell Transplantation With A Sub-myeloablative Conditioning Regimen.

Copyright © 1996-2014 The Children's Mercy Hospital